Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Ate, van der Gaast"'
Autor:
Charlène J. van der Zijden, Ben M. Eyck, Ate van der Gaast, Leni van Doorn, Joost J.M.E. Nuyttens, J. Jan B. van Lanschot, Bas P.L. Wijnhoven, Bianca Mostert, Sjoerd M. Lagarde
Publikováno v:
Contemporary Clinical Trials Communications, Vol 28, Iss , Pp 100934- (2022)
Background: FLOT and CROSS are effective neoadjuvant regimens for esophageal cancer patients. Chemotherapy (FLOT) is aimed to have merely a systemic effect whereas neoadjuvant chemoradiotherapy (CROSS) achieves good locoregional response with clinica
Externí odkaz:
https://doaj.org/article/11f5bfb8ec2d439a884eaa7e0d55bd6e
Autor:
Ben M. Eyck, Berend J. van der Wilk, Bo Jan Noordman, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Henk H. Hartgrink, Peter Paul L. O. Coene, Jan Willem T. Dekker, Michail Doukas, Ate van der Gaast, Joos Heisterkamp, Ewout A. Kouwenhoven, Grard A. P. Nieuwenhuijzen, Jean-Pierre E. N. Pierie, Camiel Rosman, Johanna W. van Sandick, Maurice J. C. van der Sangen, Meindert N. Sosef, Edwin S. van der Zaag, Manon C. W. Spaander, Roelf Valkema, Hester F. Lingsma, Ewout W. Steyerberg, J. Jan B. van Lanschot, on behalf of the SANO-study group
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-6 (2021)
Abstract Background The Surgery As Needed for Oesophageal cancer (SANO) trial compares active surveillance with standard oesophagectomy for patients with a clinically complete response (cCR) to neoadjuvant chemoradiotherapy. The last patient with a c
Externí odkaz:
https://doaj.org/article/03db1ac699e94e918426800e18e2f668
Autor:
Xiaobin Zhang, Ben M. Eyck, Yang Yang, Jun Liu, Yin-Kai Chao, Ming-Mo Hou, Tsung-Min Hung, Qingsong Pang, Zhen-Tao Yu, Hongjing Jiang, Simon Law, Ian Wong, Ka-On Lam, Berend J. van der Wilk, Ate van der Gaast, Manon C. W. Spaander, Roelf Valkema, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, J. Jan B. van Lanschot, Zhigang Li
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients with squamous cell carcinoma (SCC). An active surveillance strategy has
Externí odkaz:
https://doaj.org/article/2843509b1b4946d9b515bcdbaadad6c4
Autor:
Bo Jan Noordman, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Jurjen J. Boonstra, Peter Paul L. O. Coene, Jan Willem T. Dekker, Michael Doukas, Ate van der Gaast, Joos Heisterkamp, Ewout A. Kouwenhoven, Grard A. P. Nieuwenhuijzen, Jean-Pierre E. N. Pierie, Camiel Rosman, Johanna W. van Sandick, Maurice J. C. van der Sangen, Meindert N. Sosef, Manon C. W. Spaander, Roelf Valkema, Edwin S. van der Zaag, Ewout W. Steyerberg, J. Jan B. van Lanschot, on behalf of the SANO-study group
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Neoadjuvant chemoradiotherapy (nCRT) plus surgery is a standard treatment for locally advanced oesophageal cancer. With this treatment, 29% of patients have a pathologically complete response in the resection specimen. This provid
Externí odkaz:
https://doaj.org/article/0805a4431d264f0ebffc6b2b562c7138
Autor:
Ben M. Eyck, Berend J. van der Wilk, Maurice J.C. van der Sangen, Ate van der Gaast, J. Jan B. van Lanschot
Publikováno v:
Oesophagus and Stomach ISBN: 0192863592
Surgery has been the cornerstone of curative treatment for patients with locally advanced oesophageal cancer. Over the last decades, the addition of chemotherapy and radiotherapy to surgery has been extensively tested to improve survival outcomes. Se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::863e63bafc96cb159689703cff677193
https://doi.org/10.1093/med/9780192863591.003.0011
https://doi.org/10.1093/med/9780192863591.003.0011
Autor:
Peter de Bruijn, Sander Bins, Ferry A.L.M. Eskens, Femke M. de Man, Ron H.J. Mathijssen, Niels Heersche, Esther Oomen-de Hoop, Leni van Doorn, Ivo Bijl, Ate van der Gaast
Publikováno v:
Clinical Pharmacology and Therapeutics, 111(2), 455-460. Wiley-Blackwell
Retrospective data suggest that gastric acid reduction by proton pump inhibitors (PPIs) impairs the dissolution and subsequent absorption of capecitabine, and thus potentially reduces the capecitabine exposure. Therefore, we examined prospectively th
Autor:
Hanneke W. M. van Laarhoven, Elisabeth D. Geijsen, Paul M. Jeene, Mark I. van Berge Henegouwen, Adriana Thano, Joost J. Nuyttens, Vera Oppedijk, Maarten C.C.M. Hulshof, Maurice J.C. van der Sangen, Karen J. Neelis, Jannie G Reinders, Ate van der Gaast, Jeanin E. van Hooft, Tom Rozema, Jeroen Buijsen
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2816-2824. American Society of Clinical Oncology
Journal of Clinical Oncology, 39(25), 2816-+. American Society of Clinical Oncology
Journal of clinical oncology, 39(25), 2816-2824. American Society of Clinical Oncology
Journal of Clinical Oncology, 39(25), 2816-+. American Society of Clinical Oncology
Journal of clinical oncology, 39(25), 2816-2824. American Society of Clinical Oncology
PURPOSE To analyze the effect of radiation dose escalation to the primary tumor on local tumor control in definitive chemoradiation (dCRT) for patients with esophageal cancer. PATIENTS AND METHODS Patients with medically inoperable and/or irresectabl
Autor:
Suzanne S. Gisbertz, Bas P. L. Wijnhoven, Daan Nieboer, Liekele E. Oostenbrug, Suzan Nikkessen, Erik J. Schoon, Katharina Biermann, Lisanne K A Neijenhuis, Meindert N. Sosef, Robert G. Riedl, J. Jan B. van Lanschot, Roelf Valkema, Bo Jan Noordman, Manon C.W. Spaander, Misha D. P. Luyer, Roel J. Bennink, Michael Doukas, Mark I. van Berge Henegouwen, Mark J. Roef, Sybren L. Meijer, Kausilia K. Krishnadath, Grard A. P. Nieuwenhuijzen, Ate van der Gaast, Ineke van Lijnschoten, Berend J van der Wilk, Sjoerd M. Lagarde
Publikováno v:
Annals of Surgery, 274(6), 1009-1016. Lippincott Williams and Wilkins
Annals of surgery, 274(6), 1009-1016. Lippincott Williams and Wilkins
van der Wilk, B J, Noordman, B J, Neijenhuis, L K A, Nieboer, D, Nieuwenhuijzen, G A P, Sosef, M N, Henegouwen, M I V B, Lagarde, S M, Spaander, M C W, Valkema, R, Biermann, K, Wijnhoven, B P L, van der Gaast, A, van Lanschot, J J B, Doukas, M, Nikkessen, S, Luyer, M, Schoon, E J, Roef, M J, van Lijnschoten, I, Oostenbrug, L E, Riedl, R G, Gisbertz, S S, Krishnadath, K K, Bennink, R J & Meijer, S L 2021, ' Active Surveillance Versus Immediate Surgery in Clinically Complete Responders after Neoadjuvant Chemoradiotherapy for Esophageal Cancer : A Multicenter Propensity Matched Study ', Annals of Surgery, vol. 274, no. 6, pp. 1009-1016 . https://doi.org/10.1097/SLA.0000000000003636
Annals of Surgery, 274(6), 1009-1016. Lippincott Williams & Wilkins
Annals of surgery, 274(6), 1009-1016. Lippincott Williams and Wilkins
van der Wilk, B J, Noordman, B J, Neijenhuis, L K A, Nieboer, D, Nieuwenhuijzen, G A P, Sosef, M N, Henegouwen, M I V B, Lagarde, S M, Spaander, M C W, Valkema, R, Biermann, K, Wijnhoven, B P L, van der Gaast, A, van Lanschot, J J B, Doukas, M, Nikkessen, S, Luyer, M, Schoon, E J, Roef, M J, van Lijnschoten, I, Oostenbrug, L E, Riedl, R G, Gisbertz, S S, Krishnadath, K K, Bennink, R J & Meijer, S L 2021, ' Active Surveillance Versus Immediate Surgery in Clinically Complete Responders after Neoadjuvant Chemoradiotherapy for Esophageal Cancer : A Multicenter Propensity Matched Study ', Annals of Surgery, vol. 274, no. 6, pp. 1009-1016 . https://doi.org/10.1097/SLA.0000000000003636
Annals of Surgery, 274(6), 1009-1016. Lippincott Williams & Wilkins
Objective:This study compared outcomes of patients with esophageal cancer and clinically complete response (cCR) after neoadjuvant chemoradiotherapy (nCRT) undergoing active surveillance or immediate surgery. Background:Since nearly one-third of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca880c8f5b9d5fb6232f977d2e68900
https://research.vumc.nl/en/publications/3fd0c95b-e5e6-43cf-8306-94101747eab9
https://research.vumc.nl/en/publications/3fd0c95b-e5e6-43cf-8306-94101747eab9
Autor:
Muriel Mauer, Jack A. Roth, Stefan Michiels, Michele Valmasoni, Pierre Thirion, Ate van der Gaast, Matthew Nankivell, Bryan Burmeister, Jayne F. Tierney, Xavier Paoletti, Johanna W. van Sandick, Florent de Vathaire, Matthieu Faron, Simon Law, Jianhua Fu, Armel Maurice Cheugoua-Zanetsie, Pierre Blanchard, Jean-Pierre Pignon, Val Gebski, Ruth E Langley, Michel Ducreux, Kathryn Winter, David Cunningham
Publikováno v:
European Journal of Cancer, 157, 278-290. Elsevier Ltd.
Introduction: Which neoadjuvant treatment for locally advanced thoracic oesophagus (TE) or gastro-oesophageal junction carcinoma is best remains an open question. Randomised controlled trials variously accrued patients with adenocarcinoma and squamou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398caecaddcd75a5733cac9da156235b
https://pure.eur.nl/en/publications/d9dde01d-133c-4ce1-bd38-dc6629a2bb06
https://pure.eur.nl/en/publications/d9dde01d-133c-4ce1-bd38-dc6629a2bb06
Autor:
Leonie R Werf, Marloes Jongh, Sjoerd M. Lagarde, Eelke L A Toxopeus, Ate van der Gaast, Bas P. L. Wijnhoven, J Jan B Lanschot, Ben M Eyck, Joost J. Nuyttens
Publikováno v:
Diseases of the Esophagus. 34
Neoadjuvant chemoradiotherapy (nCRT) and surgery is a widely used treatment for locally advanced resectable oesophageal cancer, with 20 and 50% of patients having a pathological complete response (pCR). Disease, however, still recurs in 20–30% of t